# Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers

> **NCT00856713** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 72 (actual)

## Conditions studied

- Hepatic Cirrhosis

## Interventions

- **DRUG:** NRL972
- **DRUG:** NRL972
- **DRUG:** NRL972
- **DRUG:** NRL972
- **DRUG:** NRL972
- **DRUG:** NRL972

## Key facts

- **NCT ID:** NCT00856713
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-08
- **Final completion:** —
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2009-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856713, "Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00856713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*